Osteoblast-derived TGF-β1 modulates matrix degrading protease expression and activity in prostate cancer cells
Open Access
- 28 January 2000
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 85 (3), 407-415
- https://doi.org/10.1002/(sici)1097-0215(20000201)85:3<407::aid-ijc18>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Transforming growth factor-β enhances adhesion of melanoma cells to the endotheliumin vitroInternational Journal of Cancer, 1997
- Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cellsCancer, 1995
- Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in VitroBiochemical and Biophysical Research Communications, 1994
- Role of active and latent transforming growth factor β in bone formationJournal of Cellular Biochemistry, 1994
- Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cellsJournal of Cellular Physiology, 1993
- Negative regulation of gene expression by TGF‐βMolecular Reproduction and Development, 1992
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast CancerSeminars in Thrombosis and Hemostasis, 1991
- Differential effects of transforming growth factor β on human prostate cancer cells in vitroMolecular and Cellular Endocrinology, 1989
- Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-betaThe Journal of cell biology, 1988
- Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.The Journal of cell biology, 1987